To the general public, the diagnosis of breast cancer is almost exclusively associated with women. This societal narrative is so deeply ingrained that when a man discovers a lump or notices a physical change in his chest, the possibility of malignancy is often the last thing on his—or his doctor’s—mind. However, biology tells a different story. Men possess breast tissue beneath the nipple, and in rare but significant cases, that tissue can undergo malignant transformation.
The answer to the question "Can men get breast cancer?" is an unequivocal "yes." While male breast cancer accounts for approximately 1% of all breast carcinoma diagnoses, its rarity has inadvertently created a shroud of invisibility. This invisibility, fueled by social stigma, a lack of routine screening, and a deficit of male-specific clinical data, often leads to men being diagnosed at more advanced, harder-to-treat stages than their female counterparts.
At Breast Cancer Canada, the mission is clear: every patient, regardless of gender, deserves access to timely diagnostic care, inclusive representation in research, and personalized precision medicine. To bridge this gap, we must dismantle the myths and provide the Canadian public with the knowledge necessary for early detection and informed advocacy.
The Reality of the Diagnosis: Supporting Data
In Canada, breast cancer is not a "women’s disease"; it is a human disease. Statistics indicate that approximately 300 Canadian men are diagnosed with breast cancer each year. While this number may appear small relative to the thousands of women diagnosed annually, it represents 300 lives, families, and individuals who face a unique set of challenges characterized by social isolation and a healthcare system often unprepared to treat them.
Chronology of Awareness
For decades, the medical community focused almost exclusively on breast cancer in women. This historical bias resulted in a "chronology of exclusion." Because the incidence rate in men was statistically low, research funding, public awareness campaigns, and clinical guidelines bypassed the male population entirely.
Today, that trajectory is shifting. As genomic research advances, we are learning that male breast cancer is not merely a "version" of female breast cancer; it possesses distinct biological characteristics that require tailored therapeutic approaches. The lack of routine screening—such as mammograms for the general male population—remains the most significant hurdle in shifting the chronology of diagnosis from "late-stage" to "early-stage."
Recognizing the Signs: What Every Man Should Know
Because there is no standard screening program for men, self-advocacy and body awareness are the most potent tools for survival. Men should be encouraged to perform occasional self-exams, not out of fear, but out of a commitment to their own health.
Common Symptoms to Monitor
While symptoms do not always indicate cancer, any persistent change should be treated with urgency. Men should consult a physician if they notice:
- A painless lump or thickening: Typically found in the breast tissue near or behind the nipple.
- Nipple changes: Including inward turning (retraction), redness, scaling, or discharge.
- Skin changes: Dimpling, puckering, or redness of the skin over the breast area.
- Persistent pain: While many lumps are painless, any localized pain or swelling that does not resolve should be investigated.
Clinical Note: If you notice any of these signs, do not wait. Request a physical exam, and if symptoms persist, ask for diagnostic imaging, such as a targeted ultrasound or a diagnostic mammogram.
Biological Mechanisms: Types and Causes
Men can develop several of the same histological types of breast cancer as women. The vast majority of these cancers originate in the milk ducts (ductal carcinoma).
The Drivers of Male Breast Cancer
The development of breast cancer in men is rarely the result of a single event. It is usually a complex interplay of the following factors:
- Genetic Predisposition: Mutations in the BRCA2 gene are the most well-documented genetic risk factors for men. Inheriting these mutations significantly elevates the risk of both breast and prostate cancer.
- Hormonal Imbalance: Conditions that increase estrogen levels—such as obesity, cirrhosis of the liver, or certain medications—can contribute to the growth of hormone-receptor-positive breast cancers in men.
- Environmental and Occupational Exposure: Long-term exposure to radiation or certain chemicals in the workplace has been studied as a potential contributing factor, though further research is required to establish definitive links.
- Age: While the average diagnostic age for men is between 60 and 70, the disease can occur at any stage of adult life.
The Call for Precision Research
For too long, the oncology community has relied on a "one-size-fits-all" approach. Historically, clinical trials were designed for women, and men were either explicitly excluded or statistically under-represented. This means that many men have been treated with protocols derived entirely from female clinical trial data, even though the biological behavior, receptor expression, and response to treatment in male breast cancer can differ significantly.
Breast Cancer Canada’s Commitment
Breast Cancer Canada is dedicated to changing this narrative. Through initiatives like the PROgress Tracker—a national, patient-driven breast cancer registry—we are gathering the real-world data necessary to understand the male experience of the disease.
Investment in research is essential to:
- Decipher biological differences: Understanding why and how male breast cancer behaves differently at the molecular level.
- Develop male-specific clinical guidelines: Moving away from "female-centric" treatment models toward precision medicine.
- Improve quality of life: Addressing the unique psychosocial impacts of a diagnosis that carries heavy, gendered stigmas.
Frequently Asked Questions (FAQ)
Can men be screened for breast cancer?
Routine, population-level screening (mammograms) is not offered to men because the incidence rate does not justify the cost-benefit ratio for the general public. However, this does not mean screening is unavailable. Men with a known high risk—such as those with a BRCA2 mutation or a significant family history—should consult their physician to create a personalized surveillance plan, which may include regular clinical breast exams or specialized imaging.
Is genetic testing recommended for men with a family history?
Yes. If you have a family history of breast, ovarian, or prostate cancer, genetic counseling is strongly advised. A simple blood test can determine if you carry inherited mutations. Knowing your status is not just about your own health; it is about providing life-saving information to your children, siblings, and extended family.
How can men overcome the stigma of a breast cancer diagnosis?
The stigma is a psychological barrier that prevents men from seeking care. We must normalize the conversation. If you notice a change, speak up. It is not an embarrassment; it is a medical necessity. Advocate for yourself by finding a healthcare team that listens to your concerns and takes your symptoms seriously.
Implications for the Future of Healthcare
The existence of breast cancer in men is a powerful reminder that cancer does not discriminate based on gender identity. Our current healthcare infrastructure is designed for the majority, but excellence in medicine requires us to account for the minority.
As we move forward, the focus must be on three pillars: Education, Research, and Inclusion. We need to educate the medical community to look for symptoms in men, fund research that actively recruits male participants, and foster an environment where men feel safe and empowered to discuss their breast health.
When we ignore the needs of the few, we fail the standards of medicine for everyone. By shedding light on the reality of male breast cancer, we are not just helping those 300 Canadian men diagnosed each year; we are refining our entire approach to precision oncology, ensuring that every patient, regardless of who they are, receives the best care possible.
If you are concerned about your breast health, speak with your healthcare provider today. Early detection remains the most effective tool we have in the fight against cancer.
About the Author
